Articles by Larissa Ku
ADIA, GIC lead $300m round for China's Taibang Biologic
Taibang Biologic Group, a specialist in blood plasma-based pharmaceuticals formerly known as China Biologic Products, has raised a USD 300m round led by Abu Dhabi Investment Authority (ADIA) and GIC.
Portfolio: CBC Group and Ensem Therapeutics
CBC Group plans to allocate USD 300m from its latest flagship fund to a biotech incubation platform. Artificial intelligence-enabled drug discovery player Ensem Therapeutics is an example of what it wants to achieve.
China's Ribo Life Science raises $40m as part of Series E
Chinese drug developer Suzhou Ribo Life Science has raised USD 40m in the first tranche of a Series E from existing investors Panlin Capital and Trinity Innovation Fund. Several undisclosed new investors also took part.
Centurium leads $200m round for China textile tech specialist
Centurium Capital has led a USD 200m investment in NTX, a Shanghai-based textile technology start-up that aims to serve as an eco-friendly supply chain partner to fashion and apparel brands.
B Capital, Kunlun back China process mining start-up
B Capital Group and Kunlun Capital have led a CNY 135 (USD 20m) Series A extension for China’s Prothentic Technology, a process mining specialist also known as Wangfanxin.
Nue3 Capital leads Series C for Singapore's SuperAtom
Singapore-based financial technology start-up SuperAtom has raised USD 22m in Series C funding led by Malaysia's Nue3 Capital at a valuation of USD 370m.
China trucking fleet platform Duckbill raises $49m
China’s Duckbill, a fleet management platform for the trucking industry, has raised CNY 330m (USD 49m) in a Series C round led by CICC Capital.
Q&A: Monad Ventures' Norah Tian
Monad Ventures is unusual in China’s VC landscape as a dedicated software investor. Norah Tian, the firm’s founding partner, discusses valuations, deal sourcing, and gender
China VCs flock to nine-month-old CPU chip designer
Cix Technology, a China-based supplier of CPU chips, has raised a pre-Series-A funding round led by Nio Capital and Qiming Venture Partners. The size was not disclosed but the company claims to have raised USD 100m since inception.
China EV maker Hozon completes Series D with $443m tranche
Hozon Auto, a Chinese electric vehicle (EV) manufacturer, has raised CNY 3bn (USD 443m) in funding from the likes of Shenzhen Capital Group, Qianhai FoF, Hongtai Capital, Dayone Capital, Insight Capital, and Dianshi Capital.
Sequoia leads Series A for China automotive chipmaker
SiEngine Technology, a China-based developer of chips for the automotive industry, has raised around CNY 1bn (USD 148m) in a Series A round led by Sequoia Capital China.
China autonomous road sweeping start-up raises $30m
Chinese autonomous road sweeping start-up Autowise.ai has raised an extended Series B round of CNY 200m (USD 30m) featuring a VC unit of Shanghai-listed new energy company Shanshan Group.
Deal focus: Dayone champions lithium-ion alternative
In throwing its support behind Enpower Greentech, Dayone Capital hopes the Chinese company can turn solid-state batteries into a commercially viable reality for electric vehicles
Deal focus: GPs go big on China biosynthesis
Advances in synthetic biology and China’s carbon-neutral ambitions have prompted investors to re-examine bio-manufacturing plays. Mojia Biotech is among the beneficiaries
China medical big data player Aden secures $30m
Aden Technology, a China-based medical big data company specialising in insurance, has raised an extended Series B round of CNY 200m (USD 30m) led by Haier Capital with participation from Xingtuo Capital.
India fintech player Cred closes $140m Series F
Cred, an India-based credit card rewards provider, has closed a USD 140m Series F round that includes a secondary component intended to facilitate exits for existing investors.
Government funds support China's Dark Matter AI
Dmai, a Chinese cognitive artificial intelligence (AI) platform also known as Dark Matter AI, has raised RMB 500m (USD 75m) in the first tranche of a Series B round from five state-backed investors.
Profile: MSA Capital's Jenny Zeng
Having participated in Chinese private equity as GP, LP, advisor, and industry association executive, Jenny Zeng has clear ideas as to what makes a good founder. These are being put into practice at MSA Capital
Legend leads $150m Series E for China CRO ClinChoice
US and China-based clinical contract research organization (CRO) company ClinChoice has raised a USD 150m Series E round led by Legend Capital.
China IC software player raises $81m
Semi-Tech, a China-based semiconductor manufacturing software provider, has raised CNY 540m (USD 81m) across two rounds - the second extended tranche of a Series A and a Series B.
Sequoia, Dayone back China solid state battery developer
China-based Enpower Greentech, which claims to be a pioneer in next-generation all-solid-state batteries (ASSBs), has raised more than USD 20m in an extended Series A round led by Sequoia Capital China and Dayone Capital.
Joy sets modest target for China VC fund - update
Beijing-based Joy Capital has set a lower target for its latest US dollar-denominated fund than in the previous vintage and decided against raising a second accompanying growth vehicle.
China biotech: End of the boom
PE investment in China biotech has collapsed amid failed IPO processes and disputed valuations. Pockets of activity remain, though questions around commercialisation have yet to be answered
China RNA vaccine developer raises $42m
Therorna, a China-based biotech company specializing in vaccines and drugs based on circular RNA technology, has raised USD 42m in Series A funding.